β2‐adrenoceptor agonists and antagonists and risk of Parkinson's disease
Movement Disorders2018Vol. 33(9), pp. 1465–1471
Citations Over TimeTop 10% of 2018 papers
Abstract
Use of propranolol appears to be associated with an increased risk of PD, whereas use of β2-agonists is associated with a decreased risk of PD. © 2018 International Parkinson and Movement Disorder Society.
Related Papers
- → Nebulised ipratropium and salbutamol in asthma.(1986)41 cited
- → Adrenaline and nebulized salbutamol in acute asthma.(1984)20 cited
- → Single-isomer R-salbutamol is not superior to racemate regarding protection for bronchial hyperresponsiveness(2004)12 cited
- [Salbutamol in asthmatic children, lung function and plasma levels of free salbutamol after treatment with salbutamol rectally and by pressurized aerosol (author's transl)].(1980)
- [Bronchial reactivity after regular inhalation of salbutamol].(1995)